ATB — Antibiotice SA Balance Sheet
0.000.00%
- RON1.33bn
- RON1.56bn
- RON645.28m
Annual balance sheet for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.11 | 1.73 | 1.81 | 2.68 | 9.94 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 274 | 195 | 234 | 298 | 360 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 385 | 324 | 401 | 475 | 552 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 481 | 497 | 692 | 749 | 761 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 895 | 856 | 1,139 | 1,279 | 1,383 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 199 | 135 | 190 | 235 | 232 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 290 | 215 | 292 | 385 | 446 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 605 | 641 | 847 | 894 | 936 |
| Total Liabilities & Shareholders' Equity | 895 | 856 | 1,139 | 1,279 | 1,383 |
| Total Common Shares Outstanding |